Long-term interleukin 2-dependent growth and cytotoxic activity of tumor-infiltrating lymphocytes from human squamous cell carcinomas of the head and neck, Cancer Res, vol.47, issue.23, pp.6353-6362, 1987. ,
Autologous tumorspecific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor, J Exp Med, vol.168, issue.4, pp.1419-1441, 1988. ,
In situ characterization, clonogenic potential, and antitumor cytolytic activity of T lymphocytes infiltrating human brain cancers, J Neurosurg, vol.68, issue.3, pp.438-448, 1988. ,
Lymphocytes infiltrating human ovarian tumors: synergy between tumor necrosis factor alpha and interleukin 2 in the generation of CD8+ effectors from tumor-infiltrating lymphocytes, Cancer Res, vol.49, issue.21, pp.5979-5985, 1989. ,
Tumorinitiated inflammation overrides protective adaptive immunity in an induced melanoma model in mice, Cancer Res, vol.70, issue.9, pp.3515-3525, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00507316
STATs in cancer inflammation and immunity: a leading role for STAT3, Nat Rev Cancer, vol.9, issue.11, pp.798-809, 2009. ,
Natural innate and adaptive immunity to cancer, Annu Rev Immunol, vol.29, pp.235-271, 2011. ,
A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma, Science, vol.254, issue.5038, pp.1643-1647, 1991. ,
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes, Science, vol.298, issue.5594, pp.850-854, 2002. ,
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy, Clin Cancer Res, vol.17, issue.13, pp.4550-4557, 2011. ,
Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response, J Natl Cancer Inst, vol.83, issue.13, pp.932-937, 1991. ,
Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy, J Immunol, vol.173, issue.12, pp.7125-7130, 2004. ,
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens, J Clin Oncol, vol.26, issue.32, pp.5233-5239, 2008. ,
Overview of interleukin-2 as an immunotherapeutic agent, Semin Surg Oncol, vol.5, issue.6, pp.385-390, 1989. ,
Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2, JAMA, vol.271, issue.12, pp.907-913, 1994. ,
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report, N Engl J Med, vol.319, issue.25, pp.1676-1680, 1988. ,
Interleukin 2 expanded tumor-infiltrating lymphocytes in human renal cell cancer: isolation, characterization, and antitumor activity, Cancer Res, vol.48, issue.1, pp.206-214, 1988. ,
Recombinant interleukin-2-expanded tumor infiltrating lymphocytes from human renal cell cancer do not exhibit autologous tumor cell-specific cytotoxicity, Urol Int, vol.47, issue.1, pp.83-85, 1991. ,
Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2, J Natl Cancer Inst, vol.86, issue.15, pp.1159-1166, 1994. ,
Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials, J Immunol Methods, vol.102, issue.1, pp.127-141, 1987. ,
, , 1991.
, Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial, Cancer, vol.68, issue.1, pp.1-8
Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study, J Clin Oncol, vol.13, issue.8, pp.1939-1949, 1995. ,
Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients, J Immunother, vol.26, issue.4, pp.332-342, 2003. ,
LeMevel B (1991) High-fold expansion of human cytotoxic T-lymphocytes specific for autologous melanoma cells for use in immunotherapy, J Immunother, vol.10, issue.6, pp.405-411, 1991. ,
Increased intensity lymphodepletion and adoptive immunotherapy-how far can we go?, Nat Clin Pract Oncol, vol.3, issue.12, pp.668-681, 2006. ,
Enrichment of CD8+ cells from melanoma tumorinfiltrating lymphocyte cultures reveals tumor reactivity for use in adoptive cell therapy, J Immunother, vol.33, issue.5, pp.547-556, 2010. ,
In vitro predictors of therapeutic response in melanoma patients receiving tumor-infiltrating lymphocytes and interleukin-2, J Clin Oncol, vol.12, issue.7, pp.1475-1483, 1994. ,
Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells, J Exp Med, vol.200, issue.6, pp.771-782, 2004. ,
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells, J Exp Med, vol.202, issue.7, pp.907-912, 2005. ,
Ocular and systemic autoimmunity after successful tumor-infiltrating lymphocyte immunotherapy for recurrent, metastatic melanoma, Ophthalmology, vol.116, issue.5, p.981, 2009. ,
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients, J Immunother, vol.32, issue.4, pp.415-423, 2009. ,
Tumor infiltrating lymphocyte therapy for metastatic melanoma: analysis of tumors resected for TIL, J Immunother, vol.33, issue.8, pp.840-847, 2010. ,
Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol Immunother, vol.51, issue.10, pp.539-546, 2002. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482144
Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma, Cancer Immunol Immunother, vol.56, issue.11, pp.1853-1860, 2007. ,
Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients, Cancer Immunol Immunother, vol.51, issue.10, pp.532-538, 2002. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482115
Infusion of Melan-A/Mart-1 specific tumor-infiltrating lymphocytes enhanced relapse-free survival of melanoma patients, Cancer Immunol Immunother, vol.56, issue.4, pp.515-526, 2007. ,
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J Exp Med, vol.180, issue.1, pp.35-42, 1994. ,
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor, Proc Natl Acad Sci U S A, vol.91, issue.9, pp.3515-3519, 1994. ,
MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency, J Exp Med, vol.205, issue.11, pp.2673-2682, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02482029
Frequent occurrence of high affinity T cells against MELOE-1 makes this antigen an attractive target for melanoma immunotherapy, Eur J Immunol, vol.40, issue.6, pp.1786-1794, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02481945
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha, Cancer Immunol Immunother, vol.60, issue.7, pp.953-963, 2011. ,
Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1, N Engl J Med, vol.358, issue.25, pp.2698-2703, 2008. ,
Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients, J Immunol, vol.170, issue.4, pp.2161-2169, 2003. ,
Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma, J Clin Oncol, vol.24, issue.31, pp.5060-5069, 2006. ,
, , 2009.
, CD4 T cells identified in human metastatic melanoma: peptide vaccination results in selective expansion of Th1-like counterparts, Cancer Res, vol.69, issue.20, pp.8085-8093
Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma, J Immunother, vol.24, issue.4, pp.363-373, 2001. ,
Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients, Blood, vol.92, issue.5, pp.1549-1555, 1998. ,
Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor, N Engl J Med, vol.333, issue.16, pp.1038-1044, 1995. ,
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues, J Immunol, vol.160, issue.4, pp.1750-1758, 1998. ,
Optimal activation of tumorreactive T cells by selected antigenic peptide analogues, Int Immunol, vol.11, issue.12, pp.1971-1980, 1999. ,
Treatment of metastatic melanoma with autologous Melan-A/MART-1-specific cytotoxic T lymphocyte clones, J Invest Dermatol, vol.129, issue.12, pp.2835-2842, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-02481977
Adoptive transfer of tumor-reactive Melan-A-specific CTL clones in melanoma patients is followed by increased frequencies of additional Melan-Aspecific T cells, J Immunol, vol.175, issue.7, pp.4797-4805, 2005. ,
Adoptive T cell therapy using antigenspecific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells, Proc Natl Acad Sci U S A, vol.99, issue.25, pp.16168-16173, 2002. ,
White paper on adoptive cell therapy for cancer with tumorinfiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapy, Clin Cancer Res, vol.17, issue.7, pp.1664-1673, 2011. ,
Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases, Cancer Res, vol.71, issue.4, pp.1253-1262, 2011. ,
High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens, J Exp Med, vol.201, issue.2, pp.241-248, 2005. ,
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen, J Exp Med, vol.201, issue.2, pp.249-257, 2005. ,
Cancer regression in patients after transfer of genetically engineered lymphocytes, Science, vol.314, issue.5796, pp.126-129, 2006. ,
Preclinical development of T cell receptor gene therapy, Curr Opin Immunol, vol.21, issue.2, pp.209-214, 2009. ,
Enhanced antitumor activity of T cells engineered to express T-cell receptors with a second disulfide bond, Cancer Res, vol.67, issue.8, pp.3898-3903, 2007. ,
Selected murine residues endow human TCR with enhanced tumor recognition, J Immunol, vol.184, issue.11, pp.6232-6241, 2010. ,
Prospects and limitations of T cell receptor gene therapy, Curr Gene Ther, vol.11, issue.4, pp.276-287, 2011. ,
Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers, J Exp Med, vol.202, issue.3, pp.379-386, 2005. ,
Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding, Nat Med, vol.6, issue.6, pp.707-710, 2000. ,
PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting, Cancer Immunol Immunother, vol.57, issue.2, pp.185-195, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00167752
A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes, Cancer Immunol Immunother, vol.58, issue.4, pp.553-566, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-02481983
Is antigen specificity the key to efficient adoptive T-cell therapy?, Immunotherapy, vol.3, issue.4, pp.495-505, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02481934
Tumor-reactive CD4+ CD8alphabeta+ CD103+ alphabetaT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers, Int J Cancer, vol.128, issue.12, pp.2923-2932, 2011. ,
Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance, J Immunol, vol.181, issue.3, pp.2124-2133, 2008. ,
Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies, Blood, vol.115, issue.18, pp.3718-3725, 2010. ,
URL : https://hal.archives-ouvertes.fr/pasteur-01402100
Antigen choice in adoptive T-cell therapy of cancer, Curr Opin Immunol, vol.21, issue.2, pp.190-199, 2009. ,
Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm, Cancer Res, vol.70, issue.21, pp.8339-8346, 2010. ,